Artelo Biosciences, Inc. (ARTL) Misses Q2 EPS by 548c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($5.61), $5.48 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy